Provided by Tiger Trade Technology Pte. Ltd.

Iterum Therapeutics Plc

0.2438
-0.0124-4.84%
Post-market: 0.24390.0001+0.04%19:59 EST
Volume:976.72K
Turnover:238.58K
Market Cap:12.87M
PE:-0.33
High:0.2618
Open:0.2612
Low:0.2341
Close:0.2562
52wk High:1.56
52wk Low:0.2341
Shares:52.79M
Float Shares:52.38M
Volume Ratio:2.13
T/O Rate:1.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7366
EPS(LYR):-1.2576
ROE:-555.68%
ROA:-53.28%
PB:-1.74
PE(LYR):-0.19

Loading ...

Iterum Therapeutics plc held an extraordinary general meeting

Reuters
·
5 hours ago

BRIEF-Iterum Therapeutics Provides Business Update

Reuters
·
Feb 13

Iterum Therapeutics Granted U.S. Patent Covering ORLYNVAH™ Bilayer Tablet, Expiring 2039

Reuters
·
Feb 13

Iterum Therapeutics Plc - FDA Recommends Type C Meeting for Iterum's Clinical Investigation

THOMSON REUTERS
·
Feb 13

Iterum Therapeutics plc Announces Date for Upcoming Extraordinary General Meeting of Shareholders

Reuters
·
Dec 24, 2025

Iterum Therapeutics Secures Major PBM Contract for ORLYNVAH Coverage

Reuters
·
Dec 23, 2025

BRIEF-Iterum Therapeutics Provides Business Update

Reuters
·
Dec 17, 2025

Iterum Therapeutics Announces Japanese Patent Office Decision to Grant Patent Covering Sulopenem Combination, Expiring in 2041

Reuters
·
Dec 17, 2025

Iterum Therapeutics Faces Nasdaq Delisting Risk Over Listing Rule Noncompliance

Reuters
·
Dec 13, 2025

BRIEF-Iterum Therapeutics Provides Business Update

Reuters
·
Dec 05, 2025

Iterum Therapeutics Plc - Rebate Agreement Signed With Top Medicare Part D Manager

THOMSON REUTERS
·
Dec 05, 2025

Director Michael W. Dunne Acquires Common Shares of Iterum Therapeutics plc

Reuters
·
Nov 20, 2025

Iterum Therapeutics Q3 Adjusted EPS USD -0.16

THOMSON REUTERS
·
Nov 14, 2025

Iterum Therapeutics Plc: Extends Cash Runway Into Q2 2026

THOMSON REUTERS
·
Nov 14, 2025

Press Release: Iterum Therapeutics Reports Third Quarter 2025 Financial Results

Dow Jones
·
Nov 14, 2025

Top Stocks With Earnings This Week: Plug, Oklo, Circle And More

Benzinga
·
Nov 10, 2025

Iterum Therapeutics PLC expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025

Maxim Group Sticks to Their Buy Rating for Iterum Therapeutics (ITRM)

TIPRANKS
·
Oct 02, 2025

Iterum Therapeutics sees cash runway into 2026

TIPRANKS
·
Sep 19, 2025

Iterum Therapeutics - Will Continue to Explore All Available Financing Opportunities to Extend Its Operating Runway

THOMSON REUTERS
·
Sep 19, 2025